Ernst Holler Selected Research

Biomarkers (Surrogate Marker)

1/2022	Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification.
12/2020	Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin.
1/2020	Potential Novel Biomarkers in Chronic Graft-Versus-Host Disease.
1/2018	An early-biomarker algorithm predicts lethal graft-versus-host disease and survival.
1/2017	An early-biomarker algorithm predicts lethal graft-versus-host disease and survival.
1/2016	B-Cell-Based and Soluble Biomarkers in Body Liquids for Predicting Acute/Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
1/2015	Serum REG3alpha and C-Reactive Protein Levels in Crohn's Disease Patients Undergoing Immunoablation and Autologous Hemopoetic Stem Cell Transplantation in the ASTIC Trial.
1/2015	A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study.
3/2012	Plasma biomarkers of lower gastrointestinal and liver acute GVHD.
12/2011	Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ernst Holler Research Topics

Disease

77	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 09/2002
22	Bronchiolitis Obliterans Syndrome 03/2021 - 02/2006
16	Infections 01/2021 - 03/2002
15	Neoplasms (Cancer) 11/2021 - 02/2007
10	Inflammation (Inflammations) 01/2022 - 01/2007
10	Leukemia 11/2019 - 02/2006
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 11/2007
7	Crohn Disease (Crohn's Disease) 01/2015 - 08/2004
6	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 03/2002
6	Primary Myelofibrosis (Myelosclerosis) 01/2019 - 02/2007
5	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2013 - 11/2002
4	Pneumonia (Pneumonitis) 01/2021 - 08/2004
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 07/2008
3	Hodgkin Disease (Hodgkin's Disease) 01/2021 - 01/2016
3	Multiple Myeloma 11/2019 - 02/2007
3	Necrosis 02/2014 - 12/2004
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2010 - 04/2007
3	Hemolytic Anemia 02/2006 - 11/2002
2	Communicable Diseases (Infectious Diseases) 01/2021 - 10/2003
2	Colitis 01/2021 - 01/2018
2	Polyneuropathies (Polyneuropathy) 01/2021 - 01/2012
2	Nephritis 09/2020 - 11/2019
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2017 - 05/2009
2	Lymphoma (Lymphomas) 01/2016 - 12/2009
2	Hematologic Diseases (Blood Diseases) 01/2016 - 01/2012
2	Sepsis (Septicemia) 10/2013 - 07/2004
2	Neutropenia 01/2011 - 03/2002
2	Thrombocytopenia (Thrombopenia) 01/2007 - 11/2002
2	Fever (Fevers) 07/2006 - 03/2002
2	Lung Injury 03/2005 - 08/2004
2	Thrombosis (Thrombus) 09/2004 - 11/2002
1	Neoplasm Metastasis (Metastasis) 11/2021
1	Myasthenia Gravis 01/2021
1	Carcinogenesis 12/2020
1	Vasculitis (Vasculitides) 09/2020
1	Pathologic Complete Response 01/2020
1	Dysbiosis 01/2020
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2020

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2006
9	SteroidsIBA 03/2021 - 02/2006
5	CytokinesIBA 08/2005 - 03/2002
4	Proteins (Proteins, Gene)FDA Link 03/2021 - 02/2010
4	Biological ProductsIBA 02/2011 - 09/2002
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2010 - 03/2002
4	DNA (Deoxyribonucleic Acid)IBA 02/2010 - 08/2004
3	Busulfan (Busulfex)FDA Link 01/2022 - 12/2009
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2018
3	Thomsen-Friedenreich antibodiesIBA 02/2020 - 09/2009
3	GlobulinsIBA 02/2020 - 09/2009
3	fludarabineIBA 01/2020 - 07/2008
3	NucleotidesIBA 08/2015 - 07/2007
3	Methotrexate (Mexate)FDA LinkGeneric 10/2012 - 09/2004
3	Imatinib Mesylate (Gleevec)FDA Link 01/2011 - 04/2007
3	Interleukin-6 (Interleukin 6)IBA 06/2010 - 03/2002
3	NF-kappa B (NF-kB)IBA 09/2007 - 08/2004
3	AntigensIBA 02/2007 - 11/2005
2	treosulfanIBA 01/2022 - 01/2020
2	Volatile Fatty AcidsIBA 01/2022 - 01/2021
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2021 - 12/2016
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2020 - 11/2002
2	LigandsIBA 01/2018 - 08/2005
2	Anti-Bacterial Agents (Antibiotics)IBA 05/2017 - 05/2014
2	Antimicrobial PeptidesIBA 01/2017 - 08/2011
2	Hemoglobins (Hemoglobin)IBA 02/2016 - 01/2007
2	Toll-Like Receptors (Toll-Like Receptor)IBA 08/2015 - 03/2010
2	C-Reactive ProteinIBA 01/2015 - 07/2006
2	Bacterial DNAIBA 02/2014 - 08/2011
2	Pharmaceutical PreparationsIBA 05/2013 - 10/2010
2	CreatinineIBA 10/2012 - 12/2011
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2012 - 09/2009
2	ChemokinesIBA 02/2011 - 04/2009
2	Interleukin-10 (Interleukin 10)IBA 06/2010 - 12/2004
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 06/2010 - 03/2002
2	InterleukinsIBA 12/2004 - 09/2002
2	Interferon-gamma (Interferon, gamma)IBA 12/2004 - 11/2002
1	Interleukin-22 (IL-22)IBA 01/2022
1	Butyrates (Butyrate)IBA 01/2022
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2022
1	heparanaseIBA 11/2021
1	EnzymesIBA 11/2021
1	Abatacept (Orencia)FDA Link 03/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	letermovirIBA 01/2021
1	tocilizumab (atlizumab)FDA Link 04/2020
1	Fluticasone (Cutivate)FDA LinkGeneric 02/2020
1	montelukast (Singulair)FDA Link 02/2020
1	Azithromycin (Zithromax)FDA LinkGeneric 02/2020
1	Rituximab (Mabthera)FDA Link 10/2019

Therapy/Procedure

42	Stem Cell Transplantation 01/2022 - 11/2002
41	Hematopoietic Stem Cell Transplantation 01/2021 - 07/2004
20	Therapeutics 01/2021 - 10/2003
19	Transplantation 01/2022 - 11/2002
15	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2017 - 05/2004
14	Cell Transplantation 01/2022 - 07/2008
7	Homologous Transplantation 11/2019 - 07/2011
6	Drug Therapy (Chemotherapy) 01/2021 - 03/2002
4	Salvage Therapy 03/2021 - 10/2012
1	Withholding Treatment 01/2020
1	Donor Selection 11/2019
1	Renal Replacement Therapy (Therapies, Renal Replacement) 11/2019